3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
42
Lymphoma, Mantle-Cell
21
Lymphoma, Large B-Cell, Diffuse
9
Lymphoma
9
Lymphoma, Non-Hodgkin
8
Lymphoma, B-Cell
5
Waldenstrom Macroglobulinemia
4
Lymphoma, Follicular
4
Lymphoma, B-Cell, Marginal Zone
3
Leukemia, B-Cell
3
Leukemia
3
Multiple Myeloma
2
Lymphoproliferative Disorders
2
Lymphatic Diseases
2
Leukemia, Prolymphocytic
2
Recurrence
1
Pyloric Stenosis, Hypertrophic
1
Part1: Advanced B-cell Malignancies
1
Neuritis
1
Neoplasms
1
Neoplasm, Residual
1
Leukemia, Hairy Cell
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Heart Failure
1
Glioblastoma
1
Chromosome 17 deletion
1
Cardiovascular Diseases
1
Burkitt Lymphoma
1
Interventions
fludarabine
5
Cyclophosphamide
5
fludarabine phosphate
4
Whole-Body Irradiation
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Mycophenolic Acid
2
Mesna
2
Melphalan
2
Busulfan
2
Bendamustine Hydrochloride
2
AP 1903 reagent
2
pembrolizumab
1
isatuximab
1
ibrutinib
1
Lenalidomide
1
Dexamethasone
1
CLR1404
1
CA-4948
1
Bortezomib
1
Bone Marrow Transplantation
1
ARQ531
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immunoproliferative Disorders
×
acalabrutinib
×
1 year
×
Clear all
No trials found.